RNA symposium to explore translating research into medicine
All Michigan Medicine faculty and staff are invited to learn more about RNA — and how experts across the country are translating important basic biosciences research into clinical practice.
The third annual RNA Symposium will be held on Friday, March 30, in the Kahn Auditorium at BSRB. The event’s theme is “Advancing Basic RNA Biosciences into Medicine.”
The daylong event will highlight forward-looking, high-impact scientific endeavors that promise to advance a critical emerging area of the biosciences — RNA research — into enhanced clinical diagnoses, prognoses and treatments for a wide range of diseases.
“Much of the focus of precision medicine has centered around identifying and trying to translate DNA-based alterations,” said Scott Tomlins, M.D., Ph.D., of the Michigan Medicine Department of Pathology. “However, many of the next transformative advances will likely be RNA-based with clear potential impact in diagnosis, prognosis/prediction and therapeutic targeting across disease areas. That’s what we will seek to explore at this important symposium.”
Among the speakers lined up for the event is Eric Fearon, M.D., Ph.D., director of the U-M Comprehensive Cancer Center. He will deliver one of five keynote addresses. The others will be given by:
- Jonathan Weissman, Ph.D., UCSF School of Medicine
- Melissa Moore, Ph.D., UMass Medical School
- Anastasia Khvorova, Ph.D., UMAss Medical School
- Roy Parker, Ph.D., University of Colorado
In addition to the keynotes and shorter "Data Blitzes" from U-M faculty and students, the symposium will include a panel discussion on the symposium theme. A boxed lunch will be provided.
If you want to learn more about the sympsoium and register, please click here.